Patents by Inventor Keith Schappert

Keith Schappert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
    Patent number: 6573049
    Abstract: The invention provides methods for identifying or stratifying subjects having Alzheimer's disease or at risk for Alzheimer's disease by determining the genotype at nucleotide 172 of the PON1 allele of the subject.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: June 3, 2003
    Assignee: Nuvelo, Inc.
    Inventor: Keith Schappert
  • Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele
    Publication number: 20020119479
    Abstract: The invention provides methods for treating or identifying subjects having a neurological disease or at risk for a neurological disease by determining the presence of a variant GPIIIa and/or GPIIb allele.
    Type: Application
    Filed: December 7, 2001
    Publication date: August 29, 2002
    Inventor: Keith Schappert
  • Method for determining the prognosis of a patient with a neurological disease
    Publication number: 20020086290
    Abstract: The present invention provides a method for the determining the prognosis for a patient diagnosed with a neurological disease. The present invention also provides a method for the identification of human subjects for placement in clinical drug trials of drugs being tested for the treatment of neurological disease and for determining a patient's future disease risk.
    Type: Application
    Filed: April 13, 2000
    Publication date: July 4, 2002
    Inventors: Pierre Sevigny, Heiko Wiebusch, Keith Schappert
  • Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant BPIIb allele
    Patent number: 6368797
    Abstract: The invention provides methods for treating or identifying subjects having a neurological disease or at risk for a neurological disease by determining the presence of a variant GPIIIa and/or GPIIb allele.
    Type: Grant
    Filed: October 1, 1999
    Date of Patent: April 9, 2002
    Assignee: Variagenics, Inc.
    Inventor: Keith Schappert
  • Methods for treating a neurological disease by determining BCHE genotype
    Patent number: 6291175
    Abstract: Disclosed herein is a method for treating a patient with a neurological disease by determining a patient's BCHE allele status.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: September 18, 2001
    Assignees: Variagenics, Inc., Institut Pasteur de Lille
    Inventors: Pierre Sévigny, Keith Schappert, Heiko Wiebusch, Philippe Amouye
  • Method for determining the prognosis of a patient with a neurological disease
    Patent number: 6251587
    Abstract: The present invention provides a method for the determining the prognosis for a patient diagnosed with a neurological disease. The present invention also provides a method for the identification of human subjects for placement in clinical drug trials of drugs being tested for the treatment of neurological disease and for determining a patient's future disease risk.
    Type: Grant
    Filed: December 16, 1997
    Date of Patent: June 26, 2001
    Assignee: Nova Molecular, Inc.
    Inventors: Pierre Sévigny, Heiko Wiebusch, Keith Schappert